Your browser is no longer supported. Please, upgrade your browser.
LLY Eli Lilly and Company weekly Stock Chart
LLY [NYSE]
Eli Lilly and Company
IndexS&P 500 P/E42.65 EPS (ttm)2.71 Insider Own12.20% Shs Outstand971.42M Perf Week1.97%
Market Cap112.33B Forward P/E17.56 EPS next Y6.58 Insider Trans-1.07% Shs Float968.86M Perf Month-1.01%
Income2.75B PEG3.97 EPS next Q1.44 Inst Own83.20% Short Float1.17% Perf Quarter-10.96%
Sales23.95B P/S4.69 EPS this Y102.80% Inst Trans-4.82% Short Ratio2.26 Perf Half Y5.80%
Book/sh2.53 P/B45.70 EPS next Y16.97% ROA14.80% Target Price124.71 Perf Year34.34%
Cash/sh2.20 P/C52.56 EPS next 5Y10.74% ROE67.70% 52W Range84.64 - 132.13 Perf YTD-0.08%
Dividend2.58 P/FCF60.40 EPS past 5Y-5.30% ROI14.70% 52W High-12.49% Beta0.23
Dividend %2.23% Quick Ratio0.80 Sales past 5Y1.20% Gross Margin75.00% 52W Low36.61% ATR2.06
Employees38680 Current Ratio1.10 Sales Q/Q2.60% Oper. Margin12.50% RSI (14)50.15 Volatility1.33% 1.73%
OptionableYes Debt/Eq6.44 EPS Q/Q-48.70% Profit Margin26.10% Rel Volume0.49 Prev Close115.49
ShortableYes LT Debt/Eq5.49 EarningsJul 30 BMO Payout36.90% Avg Volume5.01M Price115.63
Recom2.50 SMA200.27% SMA50-0.91% SMA200-0.41% Volume2,455,645 Change0.12%
May-28-19Initiated Goldman Buy
Apr-24-19Upgrade Edward Jones Hold → Buy
Apr-11-19Downgrade Guggenheim Buy → Neutral
Mar-12-19Initiated JP Morgan Overweight $140
Jan-23-19Initiated UBS Buy $131
Nov-26-18Downgrade Citigroup Buy → Neutral
Oct-31-18Upgrade Credit Suisse Underperform → Neutral
Oct-09-18Initiated Guggenheim Buy
Oct-01-18Reiterated SunTrust Buy $105 → $123
Sep-26-18Resumed JP Morgan Overweight $117
Jul-25-18Downgrade Berenberg Buy → Hold
Jun-08-18Initiated Cantor Fitzgerald Overweight $100
Apr-13-18Upgrade BMO Capital Markets Underperform → Market Perform $74 → $79
Jan-22-18Downgrade Credit Suisse Neutral → Underperform
Jan-16-18Downgrade Goldman Buy → Neutral
Jan-05-18Upgrade Argus Hold → Buy
Oct-10-17Downgrade Credit Suisse Outperform → Neutral
Jul-26-17Downgrade Leerink Partners Outperform → Mkt Perform
Apr-27-17Downgrade Argus Buy → Hold
Apr-17-17Downgrade Morgan Stanley Overweight → Equal-Weight
Jun-24-19 04:23PM  Why These Innovative Biotech ETFs Soaring Zacks
10:27AM  Allergan's Botox Wins FDA Nod for Upper Limb Spasticity in Kids Zacks
Jun-20-19 09:23AM  Allergan Up As Analyst Statement Sparks Business Split Rumors Zacks
Jun-19-19 12:05PM  Lilly Declares Third-Quarter 2019 Dividend PR Newswire
Jun-18-19 09:51AM  Pfizer to Buy Array BioPharma, Broaden Cancer Portfolio Zacks
09:18AM  Novo Nordisk's Victoza Gets FDA Nod for Pediatric Patients Zacks
07:09AM  Shares of cancer-therapy companies skyrocket after Pfizer acquisition news MarketWatch
Jun-17-19 09:35AM  Pfizer Expands in Cancer With $10.6 Billion Deal for Array Bloomberg
09:30AM  Pfizer's $11 Billion Cancer-Drug Deal Takes Pricey Path to Growth Bloomberg
09:15AM  Are You Looking for a High-Growth Dividend Stock? Eli Lilly (LLY) Could Be a Great Choice Zacks
Jun-14-19 03:14PM  U.S. drugmakers file lawsuit against rule requiring drug prices in TV ads Reuters
08:42AM  Pharma Stock Roundup: MRK Buys Small Cancer Biotech, RHHBY, MRK Drugs Get FDA Nod Zacks
06:45AM  Lilly Presents Positive Results for Taltz® (ixekizumab) vs. Humira® (adalimumab) in a Head-to-Head (SPIRIT-H2H) Superiority Study in Patients with Active Psoriatic Arthritis at the European Congress of Rheumatology PR Newswire
05:19AM  Drugmakers sue to stop rule requiring prices in TV ads Financial Times
Jun-13-19 04:12PM  Amgen, Biogen, Gilead and Novo Nordisk have very high capacity for M&A, says Moodys MarketWatch
10:26AM  NuCana's Biliary Tract Cancer Candidate Gets Orphan Drug Tag Zacks
10:14AM  Eli Lilly Broke Below the 200-Day Average to Change the Narrative to Bearish TheStreet.com
08:24AM  Pfizer's (PFE) Xeljanz Effective As Monotherapy in RA Study Zacks
Jun-12-19 07:01PM  Jim Cramer: A Tale of Two Stocks TheStreet.com
06:38PM  Galapagos Ends Enrollment in Osteoarthritis Study Before Time Zacks
08:28AM  Boost Your Portfolio's Health With These 3 Big Drug Stocks Zacks
Jun-11-19 04:06PM  13 Blue-Chip Stocks With Risks You Need to Watch Kiplinger
11:19AM  The Zacks Analyst Blog Highlights: Oracle, Eli Lilly, Mondelez, Walgreens and Southwest Zacks
09:03AM  Lilly Announces Tradjenta Cardiovascular Outcome Study Data Zacks
08:53AM  Merck (MRK) to Buy Private Biotech Tilos for Up to $773M Zacks
07:34AM  The Daily Biotech Pulse: Lilly Reports Positive Long-Term Efficacy Data For Psoriasis Drug, Provention Bio Offering Benzinga
03:00AM  Lilly to Present 5-Year Sustained Efficacy and Safety Results for Taltz® (ixekizumab) in Patients with Plaque Psoriasis at the World Congress of Dermatology PR Newswire
Jun-10-19 09:30PM  Detailed findings from CAROLINA® outcome trial support long-term cardiovascular safety profile of Tradjenta® PR Newswire
02:47PM  Top Analyst Reports for Oracle, Eli Lilly & Mondelez Zacks
01:00PM  New analysis shows cardiorenal risk reductions of Jardiance® are consistent in adults with type 2 diabetes, cardiovascular disease and kidney disease without overt proteinuria PR Newswire
09:57AM  The Zacks Analyst Blog Highlights: Bristol Myers, Merck, Roche, Lilly and AstraZeneca Zacks
09:13AM  Eli Lilly stock down 2.4% after Trulicity trial misses investors' expectations MarketWatch
09:06AM  Eli Lilly Stock Is Falling and Novo Nordisk Is Rising on Diabetes-Drug Results Barrons.com
08:40AM  Lilly (LLY) Presents Data From Diabetes Studies at ADA Meet Zacks
08:29AM  Thor Industries and Eli Lilly Offer a Tale of Two Stocks TheStreet.com
Jun-09-19 07:30PM  Trulicity® (dulaglutide) significantly reduced major cardiovascular events for broad range of people with type 2 diabetes PR Newswire
11:30AM  Lilly's ultra rapid lispro provided similar A1C reductions compared to Humalog® (insulin lispro), with superior post-meal blood glucose reductions PR Newswire
Jun-08-19 08:30PM  Lilly's tirzepatide demonstrates benefits in data presented at the American Diabetes Association's® 79 Scientific Sessions® PR Newswire
Jun-07-19 01:53PM  Heres What Hedge Funds Think About Eli Lilly and Company (LLY) Insider Monkey
10:21AM  Pharma Stock Roundup: ASCO Update, FDA Nod for LLY's Emgality for Cluster Headache Zacks
Jun-06-19 03:26PM  Incyte Begins Phase III Study for Treatment of Duct Cancer Zacks
09:22AM  Lilly's Emgality Gets FDA Approval for Cluster Headache Zacks
06:45AM  Lilly to Present New Data and Commitment to Patient-Centered Solutions at the Annual European Congress of Rheumatology PR Newswire
Jun-05-19 01:25PM  Eli Lilly Takes Aim at Chronic Pain Problem, Alleviating Opiate Addiction TheStreet.com
12:53PM  Eli Lilly gets FDA approval for cluster headache medication Yahoo Finance Video
12:21PM  How Merck reached new ground in the fight against cancer Yahoo Finance Video
07:30AM  The Daily Biotech Pulse: Curtains Down On ASCO, Rewalk Flies, Eli Lilly's Migraine Drug Approved For Cluster Headache Benzinga
06:45AM  Lilly to Showcase Scientific Innovation within Dermatology Portfolio at 24th World Congress of Dermatology PR Newswire
06:39AM  Eli Lilly's Emgality gets FDA approval for episodic cluster headaches MarketWatch
Jun-04-19 09:01PM  FDA Approves Emgality® (galcanezumab-gnlm) as the First and Only Medication for the Treatment of Episodic Cluster Headache that Reduces the Frequency of Attacks PR Newswire
05:06PM  FDA approves Lilly's migraine drug as first ever cluster headache treatment Reuters
10:26AM  Celldex Presents Data From CDX-3379 Study at ASCO, Stock Down Zacks
09:21AM  3 Cancer Stocks Given a Lift by Amgen Motley Fool
07:30AM  U.S. FDA Accepts New Drug Application for Triple Combination Tablet for Adults with Type 2 Diabetes PR Newswire
Jun-03-19 02:46PM  Why Cancer-Fighting Stocks & ETFs Are Soaring Zacks
01:33PM  Which Pharmaceutical Stocks Are Outperforming All Other Stocks? Investor's Business Daily
09:39AM  Merck's Keytruda Improves 5-Year Survival in Lung Cancer Zacks
May-31-19 07:00AM  Hurricane Season is Almost Here. Are You Ready? PR Newswire
May-30-19 04:15PM  Lilly to Participate in Goldman Sachs Global Healthcare Conference PR Newswire
09:31AM  Lilly (LLY) Down 2.3% Since Last Earnings Report: Can It Rebound? Zacks
May-29-19 04:24PM  5 Pharmaceutical Stocks With Big Moats and Bridges Kiplinger
04:15PM  Lilly Announces Webcast to Discuss ADA Presentations and Diabetes Portfolio PR Newswire
10:31AM  Lilly In-Licenses Private Biotech's Non-Opoid Pain Candidate Zacks
09:52AM  Pro-choice groups lost in Alabama despite outspending the pro-life side by 100-to-1 MarketWatch
07:42AM  Bayer to work with Foundation Medicine on selecting cancer patients Reuters
07:39AM  3 Big Stock Charts for Wednesday: Juniper Networks, Eli Lilly and Hormel Foods InvestorPlace
May-28-19 03:36PM  This Just In: Goldman Sachs Picks 4 Big Pharma Stocks to Buy Motley Fool
11:30AM  British Columbia to be first Canadian province to switch patients to biosimilars Reuters
07:54AM  Lilly Announces Licensing Agreement for Non-Opioid Pain Asset from Centrexion Therapeutics PR Newswire
May-27-19 06:05PM  British Columbia will be first Canadian province to switch patients to biosimilars Reuters
09:17AM  Incyte (INCY) Receives FDA Nod for Label Expansion of Jakafi Zacks
May-24-19 09:56AM  Nektar (NKTR) Announces Formation of CNS-Focused Subsidiary Zacks
09:30AM  Pharma Stock Roundup: MRK's Cancer Biotech Buyout, ABBV, LLY's Pipeline Updates Zacks
May-23-19 03:53PM  Earnings Preview: Veeva (VEEV), Palo Alto Networks (PANW), Workday (WDAY) Zacks
10:38AM  Amgen (AMGN) Offers to Acquire Drug Discovery Platform Zacks
09:08AM  Lilly (LLY) Launches Half-Priced Version of Humalog Insulin Zacks
08:20AM  J&J's Invokana sNDA Gets Priority Review Status From FDA Zacks
May-22-19 05:13PM  Array BioPharma Gains on Colorectal Cancer Study Success Zacks
04:30PM  3 Tech Stocks for Growth Investors to Buy Right Now Zacks
02:31PM  Eli Lilly says lower-priced insulin is now available Yahoo Finance Video
11:26AM  Should We Worry About Eli Lilly and Company's (NYSE:LLY) P/E Ratio? Simply Wall St.
09:50AM  Lilly's Crohn's Disease Candidate Meets Phase II Study Goals Zacks
09:37AM  Merck to Buy Private Cancer Drugmaker Peloton Therapeutics Zacks
06:53AM  Eli Lilly's Insulin Lispro Injection available at half the list price of Humalog MarketWatch
06:46AM  Lilly selling half-price version of popular Humalog insulin Associated Press
06:30AM  Lilly's Lower-Priced Insulin Now Available PR Newswire
May-21-19 04:16PM  Why This Biotech Stock Succeeded In Colon Cancer As Others Struggled Investor's Business Daily
01:15PM  Lilly's Mirikizumab Met Primary Endpoint and Key Secondary Endpoints in Phase 2 Study, Including Reductions of Gastrointestinal Lesions PR Newswire
08:13AM  Merck agrees $1bn deal to buy biopharmaceutical company Peloton Financial Times
May-20-19 12:04PM  Credit Suisse Absolutely Is Right to Double Down on Pfizer Stock InvestorPlace
09:15AM  Why Eli Lilly (LLY) is a Top Dividend Stock for Your Portfolio Zacks
May-19-19 09:00AM  Better Buy: Eli Lilly vs. Pfizer Motley Fool
May-18-19 09:50AM  The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trial Readouts And IPOs Benzinga
May-17-19 08:35AM  Pharma Stock Roundup: FDA Okays Line Extensions of LLY, PFE, ABBV Cancer Drugs Zacks
May-16-19 04:30PM  Lilly to Participate in UBS Global Healthcare Conference PR Newswire
08:20AM  Pfizer's Eczema Candidate Meets All Goals in Phase III Study Zacks
May-15-19 05:00PM  Data Presentations at ASCO 2019 Highlight Lilly's Targeted Approach to Developing Treatments for Patients Living with Cancer PR Newswire
10:16AM  3 Stocks With Big News Coming at ASCO 2019 Motley Fool
09:12AM  The Zacks Analyst Blog Highlights: Alphabet, Eli Lilly, CVS, Marriott and TELUS Zacks
09:07AM  3 Top Diabetes Stocks to Watch in May Motley Fool
Eli Lilly and Company discovers, develops, manufactures, and markets pharmaceutical products worldwide. The company operates in two segments, Human Pharmaceutical Products and Animal Health Products. It offers endocrinology products for the treatment of diabetes; osteoporosis in postmenopausal women and men; and human growth hormone deficiency and pediatric growth conditions. The company also provides neuroscience products for the treatment of depressive disorder, diabetic peripheral neuropathic pain, anxiety disorder, fibromyalgia, and chronic musculoskeletal pain; schizophrenia; attention-deficit hyperactivity disorder; obsessive-compulsive disorder, bulimia nervosa, and panic disorder; and positron emission tomography imaging of beta-amyloid neurotic plaques in adult brains, as well as migraine prevention. In addition, it offers immunology products for the treatment of rheumatoid arthritis and plaque psoriasis; oncology products to treat non-small cell lung, colorectal, head and neck, pancreatic, metastatic breast, ovarian, bladder, and metastatic gastric cancers, as well as malignant pleural mesothelioma; and cardiovascular products to treat erectile dysfunction and benign prostatic hyperplasia, and acute coronary syndrome. Further, the company provides animal health products, such as cattle feed additives; leanness and performance enhancers for swine and cattle; antibiotics to treat respiratory and enteric diseases in swine and poultry; anticoccidial agents for poultry use; and chewable tablets that kill fleas and prevent heartworm diseases. Additionally, it offers vaccines to prevent bordetella, Lyme disease, rabies, and parvovirus. The company has collaboration agreements with Daiichi Sankyo Co., Ltd.; Incyte Corporation; Pfizer Inc.; AstraZeneca; Nektar Therapeutics; NextCure, Inc.; Dicerna Pharmaceuticals; AC Immune SA; and Avidity Biosciences, Inc. Eli Lilly and Company was founded in 1876 and is headquartered in Indianapolis, Indiana.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Smiley Joshua LSVP and CFOJun 05Buy118.0342650,28130,410Jun 05 02:15 PM
Harrington Michael JSenior VP and General CounselJun 03Sale116.7216,0001,867,520110,300Jun 04 01:57 PM
Shaw ChristiSVP and Pres., Lilly Bio-MedsMay 03Sale117.147,577887,5700May 07 02:18 PM
Shaw ChristiSVP and Pres., Lilly Bio-MedsMay 01Option Exercise0.0013,750013,750May 03 04:04 PM
Zulueta Alfonso GSVP & President, Lilly Int'lApr 12Sale124.6510,0001,246,50057,806Apr 16 02:48 PM
Barnes Melissa SChief Eth/Cmpl Ofcr & SVP, ERMApr 12Sale125.154,735592,58522,085Apr 16 02:36 PM
Shah Aarti S.SVP & CIOApr 05Sale125.851,800226,53018,425Apr 08 02:54 PM
LILLY ENDOWMENT INC10% OwnerMar 26Sale131.41205,00026,938,688116,810,304Mar 27 02:57 PM
Zakrowski Donald AChief Accounting OfficerMar 22Sale128.501,000128,5004,595Mar 22 03:16 PM
Fry Stephen FSVP, HR & DiversityMar 12Sale123.1614,8471,828,557109,663Mar 13 12:47 PM
LILLY ENDOWMENT INC10% OwnerMar 01Sale128.43210,00026,971,215117,015,304Mar 04 02:13 PM
Zakrowski Donald AChief Accounting OfficerMar 01Sale127.011,000127,0105,595Mar 05 03:51 PM
LILLY ENDOWMENT INC10% OwnerFeb 28Sale126.73200,00025,345,017117,225,304Mar 01 01:25 PM
LILLY ENDOWMENT INC10% OwnerFeb 22Sale124.19195,00024,217,635117,425,304Feb 25 04:06 PM
LILLY ENDOWMENT INC10% OwnerFeb 19Sale122.48205,00025,108,513117,620,304Feb 20 01:35 PM
Norton JohnaSenior VP, Global QualityFeb 16Option Exercise0.0048082Feb 20 03:52 PM
Conterno Enrique ASVP&Pres, LillyDiab & LillyUSAFeb 15Sale121.0025,0003,025,000132,962Feb 20 03:37 PM
O'Neill MylesSVP & Pres., Mfg. OperationsFeb 01Option Exercise0.003,221054,175Feb 06 08:10 PM
Zulueta Alfonso GSVP & President, Lilly Int'lFeb 01Option Exercise0.009,722050,946Feb 05 07:09 PM
Ricks David APresident & CEOFeb 01Option Exercise0.0012,2220131,708Feb 05 07:04 PM
Harrington Michael JSenior VP and General CounselFeb 01Option Exercise0.0012,7780102,548Feb 05 06:59 PM
Fry Stephen FSVP, HR & DiversityFeb 01Option Exercise0.008,8890109,100Feb 05 06:55 PM
Conterno Enrique ASVP&Pres, LillyDiab & LillyUSAFeb 01Option Exercise0.0012,2220136,756Feb 05 06:49 PM
Barnes Melissa SChief Eth/Cmpl Ofcr & SVP, ERMFeb 01Option Exercise0.003,333020,901Feb 05 06:43 PM
LILLY ENDOWMENT INC10% OwnerJan 17Sale118.33136,57716,161,281117,825,304Jan 18 01:14 PM
LILLY ENDOWMENT INC10% OwnerJan 16Sale117.871,657195,315117,961,881Jan 17 01:15 PM
LILLY ENDOWMENT INC10% OwnerJan 15Sale117.7451,7666,095,136117,963,538Jan 16 02:36 PM
O'Neill MylesSVP & Pres., Mfg. OperationsDec 10Sale112.9225,0002,822,95950,954Dec 12 03:15 PM
LILLY ENDOWMENT INC10% OwnerDec 04Sale119.0015,5001,844,536118,015,304Dec 06 03:43 PM
White Anne E.SVP & Pres-Lilly OncologyDec 02Option Exercise0.007,500017,103Dec 04 03:14 PM
LILLY ENDOWMENT INC10% OwnerNov 29Sale117.42185,00021,722,429118,030,804Nov 30 11:52 AM
LILLY ENDOWMENT INC10% OwnerNov 28Sale115.57190,00021,957,939118,215,804Nov 29 10:55 AM
LILLY ENDOWMENT INC10% OwnerNov 19Sale115.31195,00022,485,572118,405,804Nov 20 02:40 PM
LILLY ENDOWMENT INC10% OwnerNov 16Sale113.74200,00022,747,000118,600,804Nov 19 01:53 PM
LILLY ENDOWMENT INC10% OwnerNov 13Sale113.412,460278,979118,800,804Nov 14 10:44 AM
LILLY ENDOWMENT INC10% OwnerNov 12Sale113.48202,54022,984,877118,803,264Nov 13 10:51 AM
LILLY ELI & CO10% OwnerNov 06Sale14.00700,0009,800,0003,148,647Nov 08 11:34 AM
Norton JohnaSenior VP, Global QualityNov 03Option Exercise0.003,133019,225Nov 06 01:25 PM
LILLY ENDOWMENT INC10% OwnerOct 17Sale113.25174,69619,783,623119,005,804Oct 18 02:26 PM
LILLY ENDOWMENT INC10% OwnerOct 09Sale115.9110,6721,237,013119,180,500Oct 10 01:17 PM
LILLY ENDOWMENT INC10% OwnerOct 08Sale115.9114,6321,696,039119,191,172Oct 09 01:14 PM
LILLY ENDOWMENT INC10% OwnerOct 04Sale112.67116,03813,073,950119,205,804Oct 05 02:47 PM
Zulueta Alfonso GSVP & President, Lilly Int'lOct 04Sale114.647,000802,48045,224Oct 05 02:08 PM
LILLY ENDOWMENT INC10% OwnerOct 03Sale109.0178,9628,607,253119,321,842Oct 04 02:29 PM
LILLY ENDOWMENT INC10% OwnerSep 28Sale107.31107,55311,541,082119,400,804Oct 01 11:53 AM
LILLY ENDOWMENT INC10% OwnerSep 27Sale107.0092,4479,891,644119,508,357Sep 28 10:36 AM
LILLY ENDOWMENT INC10% OwnerSep 26Sale106.63134,41014,332,373119,600,804Sep 27 12:26 PM
LILLY ENDOWMENT INC10% OwnerSep 25Sale106.4155,5905,915,165119,735,214Sep 26 01:49 PM
LILLY ELI & CO10% OwnerSep 24Sale16.362,02733,1623,848,647Sep 26 02:50 PM
LILLY ELI & CO10% OwnerSep 18Sale14.566,870100,0273,850,674Sep 20 04:50 PM
Zulueta Alfonso GSVP & President, Lilly Int'lSep 18Sale107.003,000321,00052,224Sep 19 05:47 PM
Zulueta Alfonso GSVP & President, Lilly Int'lSep 17Sale105.613,000316,83055,224Sep 19 05:47 PM
LILLY ELI & CO10% OwnerSep 17Sale14.586,865100,0923,857,544Sep 18 07:30 PM
LILLY ELI & CO10% OwnerSep 14Sale14.589,009131,3513,864,409Sep 18 07:30 PM
LILLY ELI & CO10% OwnerSep 13Sale14.3220,900299,2883,873,418Sep 14 03:34 PM
LILLY ELI & CO10% OwnerSep 12Sale14.8310,059149,1753,894,318Sep 14 03:34 PM
LILLY ELI & CO10% OwnerSep 11Sale14.8711,277167,6893,904,377Sep 12 04:39 PM
LILLY ELI & CO10% OwnerSep 10Sale14.444,50064,9803,915,654Sep 12 04:39 PM
LILLY ENDOWMENT INC10% OwnerSep 07Sale106.76180,00019,217,055119,790,804Sep 10 12:44 PM
Zakrowski Donald AChief Accounting OfficerSep 04Sale105.5760063,3423,530Sep 04 04:50 PM
LILLY ELI & CO10% OwnerAug 31Sale14.267009,9823,920,154Sep 04 03:38 PM
LILLY ENDOWMENT INC10% OwnerAug 30Sale105.42190,00020,030,370119,970,804Aug 31 09:07 AM
LILLY ELI & CO10% OwnerAug 30Sale14.353,44049,3643,920,854Aug 31 12:40 PM
LILLY ELI & CO10% OwnerAug 29Sale14.262,31232,9693,924,294Aug 31 12:40 PM
LILLY ENDOWMENT INC10% OwnerAug 20Sale105.89195,00020,647,575120,160,804Aug 21 02:12 PM
LILLY ENDOWMENT INC10% OwnerAug 16Sale104.50200,00020,899,800120,355,804Aug 17 03:08 PM
LILLY ENDOWMENT INC10% OwnerAug 15Sale103.23151,79315,669,440120,555,804Aug 16 02:52 PM
LILLY ELI & CO10% OwnerAug 14Sale14.283,00042,8403,926,606Aug 16 03:34 PM
LILLY ELI & CO10% OwnerAug 13Sale14.334,53164,9293,929,606Aug 14 05:04 PM
LILLY ENDOWMENT INC10% OwnerAug 10Sale103.063,587369,676120,707,597Aug 13 03:41 PM
LILLY ELI & CO10% OwnerAug 10Sale14.281,89827,1033,934,137Aug 14 05:04 PM
LILLY ENDOWMENT INC10% OwnerAug 07Sale103.2224,6202,541,326120,711,184Aug 08 01:28 PM
LILLY ENDOWMENT INC10% OwnerAug 06Sale102.15195,00019,918,860120,735,804Aug 07 11:46 AM
LILLY ELI & CO10% OwnerAug 03Sale13.551,65022,3583,936,035Aug 07 03:16 PM
LILLY ELI & CO10% OwnerAug 02Sale13.3119,400258,2143,937,685Aug 03 03:53 PM
LILLY ENDOWMENT INC10% OwnerAug 02Sale99.58190,00018,919,939120,930,804Aug 03 02:31 PM
LILLY ENDOWMENT INC10% OwnerJul 31Sale98.74205,00020,240,873121,120,804Aug 01 01:12 PM
TAI JACKSON PDirectorJul 26Buy95.222,168206,43753,228Jul 27 10:46 AM
LILLY ENDOWMENT INC10% OwnerJul 25Sale94.73190,00017,999,259121,325,804Jul 26 02:17 PM
LILLY ENDOWMENT INC10% OwnerJul 24Sale92.03185,00017,025,985121,515,804Jul 25 11:47 AM
LILLY ENDOWMENT INC10% OwnerJul 06Sale87.44180,00015,738,300121,700,804Jul 09 10:45 AM
Pusey Leigh AnnSVP, Corp. Affairs & Comm.Jul 05Option Exercise0.002,39402,394Jul 09 11:58 AM
LILLY ENDOWMENT INC10% OwnerJul 05Sale86.62170,00014,725,740121,880,804Jul 06 11:13 AM